Anti-GD2/Anti-CD56 4SCAR-expressing Bispecific T-cells

Preferred Label : Anti-GD2/Anti-CD56 4SCAR-expressing Bispecific T-cells;

NCIt synonyms : Anti-GD2/CD56 Bispecific 4SCAR-expressing T-cells; Anti-GD2/Anti-NCAM-1 4SCAR-expressing Bispecific T-cells; Bi-4SCAR GD2/CD56 T Cells; Anti-CD56/Anti-GD2 4SCAR-expressing Bispecific T-cells; GD2/CD56 Bispecific 4SCAR-T Cells;

NCIt definition : A preparation of T-lymphocytes that are genetically engineered to express a fourth-generation chimeric antigen receptor (4SCAR) targeting the two tumor-associated antigens (TAAs) disialoganglioside (GD2) and CD56 (neural cell adhesion molecule 1; NCAM-1), with potential immunostimulating and antineoplastic activities. Upon administration, the anti-GD2/anti-CD56 4SCAR-expressing bispecific T-cells are directed to and induce selective toxicity in GD2- and CD56-expressing tumor cells. GD2 is overexpressed on the surface of neuroblastoma cells and by other neuroectoderm-derived neoplasms, while it is minimally expressed on normal cells. CD56 is overexpressed on the surface of various types of cancer cells, including small cell lung cancer (SCLC) and other neuroendocrine tumors (NETs).;

NCI Metathesaurus CUI : CL1794067;

Details

Origin ID

C188801;

UMLS CUI

C5708041;

Semantic type(s)
- Cell [UMLS semantic type]
chemical_or_drug_affects_cell_type_or_tissue
- Cytotoxic T-Lymphocyte [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Immunopotentiation [NCIt concept]
- T-Cell Activation [NCIt concept]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Ganglioside GD2 [NCIt concept]
- Neural Cell Adhesion Molecule 1 [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients